PH
Patricia C Hirano
See Remarks

Patricia C Hirano insider trades: Soleno Therapeutics (SLNO) stock sales

See Remarks, Soleno Therapeutics Last trade Jul 1, 2025 29 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
14
Open-market trades
since 2023
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Patricia reports to the SEC

Open-market buys and sales

14 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 1, 2025SLNO↓ Sell$317K
Jun 24, 2025SLNO↓ Sell$22K
Apr 1, 2025SLNO↓ Sell$265K
Mar 28, 2025SLNO↓ Sell$10.7M
Jan 3, 2025SLNO↓ Sell$139K
Oct 1, 2024SLNO↓ Sell$154K
Aug 29, 2024SLNO↓ Sell$508K
Aug 6, 2024SLNO↓ Sell$502K
Jul 1, 2024SLNO↓ Sell$90K
Apr 1, 2024SLNO↓ Sell$92K
Jan 25, 2024SLNO↓ Sell$40K
Dec 14, 2023SLNO↓ Sell$239K
Nov 30, 2023SLNO↓ Sell$110K
Nov 29, 2023SLNO↓ Sell$203K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other SLNO insiders

Open-market trades in the last 12 months

About Patricia C Hirano's insider trades

Patricia C Hirano is See Remarks at Soleno Therapeutics (SLNO). Since Nov 29, 2023, Patricia has reported no open-market purchases and 14 sales worth $13.4M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (12 filings), shares withheld for taxes (2 filings), option exercises (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SLNO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.